DRAXIS and University of Toronto Drop Anipryl Lawsuits

Law360, New York (November 19, 2003, 12:00 AM EST) -- DRAXIS Health, the University of Toronto and the University's Innovation Foundation have mutually agreed to settle their lawsuits over canine medicine Anipryl, the organizations said in a statement.

They said the settlement involved no payments. The animal health subsidiary of DRAXIS will continue to license the animal health applications of l-deprenyl technologies owned by UTIF.

On July 28, 2000, the University of Toronto announced that negotiations with drug manufacturer Draxis had ended and that it had filed a $100 million lawsuit claiming that Anipryl belongs the...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.